Rowasa

Overview

About Rowasa

Special information if you are pregnant or breastfeeding

Pregnant women should use mesalamine only if clearly needed. Mesalamine has been found in breast milk. If Rowasa is essential to your health your doctor may advise you to discontinue breastfeeding until your treatment is finished.

Recommended dosage for Rowasa

ADULTS

Rowasa Suspension Enema

The usual dose is 1 rectal enema (60 milliliters) per day, preferably used at bedtime and retained for about 8 hours. Treatment time usually lasts from 3 to 6 weeks, although improvement may be seen within 3 to 21 days.

Rowasa Suppositories

The usual dose is one rectal suppository (500 milligrams) 2 times a day. To get the most benefit from the suppository, it should be retained for 1 to 3 hours or longer.

Canasa Suppositories

The recommended dose is 1 rectal suppository (500 milligrams) 2 times a day for 3 to 6 weeks. To get the most benefit from the suppository, it should be retained for 1 to 3 hours or longer. The dosage may be increased to 3 suppositories daily if response is unsatisfactory after 2 weeks of therapy. For the 1,000-milligram suppository, the recommended dose is 1 rectal suppository at bedtime for 3 to 6 weeks. Improvement may be seen within 3 to 21 days.

Pentasa Capsules

The usual dose is 1 gram (four 250-milligram or two 500-milligram capsules) 4 times per day for a total of 4 grams. Treatment usually lasts for up to 8 weeks.

Asacol Tablets

The recommended dose for the treatment of ulcerative colitis is 2 tablets 3 times a day for 6 weeks.

To prevent a relapse, the usual dosage is 4 tablets a day, taken in 2 or more smaller doses, for 6 months.

CHILDREN

Safety and effectiveness in children have not been established.

Overdosage

There have been no proven reports of serious effects resulting from overdoses of Rowasa or Canasa. An overdose of Pentasa or Asacol could cause any of the following symptoms: